Stock Veränderung Datum
AbbVie USD 5.05B 98M 2026-03
Agios Pharmaceuticals USD 35.09M 2.17M 2026-03
Alnylam Pharmaceuticals USD 200.15M 117.43M 2026-03
Amgen USD 6.19B 39M 2026-03
Arrowhead Research USD -173.08M 173.08M 2024-12
Astellas Pharma JPY 297.26B 9.92B 2025-03
AstraZeneca USD 6.57B 13M 2026-03
Bayer EUR 12.34B 3M 2025-12
Biogen USD 1.95B 219.1M 2026-03
BioMarin Pharmaceutical USD 1.27B 25.66M 2026-03
Bristol-Myers Squibb USD 2.76B 66M 2026-03
Daiichi Sankyo JPY 608.55B 93.64B 2025-09
Eli Lilly USD 14.53B 785M 2026-03
Exelixis USD 26.6M 4.92M 2026-03
Gilead Sciences USD 1.91B 140M 2026-03
GlaxoSmithKline GBP 6.16B 233M 2026-03
Incyte USD 115.62M 14.56M 2026-03
Ionis Pharmaceuticals USD 5.56M 4.49M 2026-03
Merck USD 6.48B 179M 2026-03
Moderna USD 146M 7M 2026-03
Nektar Therapeutics USD 14.46M 1.78M 2024-06
Novartis USD 6.29B 17M 2026-03
Novartis USD 6.42B 114M 2025-09
Pfizer USD 10.67B 13M 2026-03
Puma Biotechnology USD 9.48M 885K 2025-09
Regeneron Pharmaceuticals USD 3.1B 97.2M 2026-03
Roche Holding CHF 7.6B 9M 2025-06
Sarepta Therapeutics USD 1B 86.37M 2026-03
Vertex Pharmaceuticals USD 1.77B 79.9M 2026-03